Directory
>
Jannik Andersen
Jannik Andersen
Chief Scientific Officer | Tango Therapeutics
Cambridge, Massachusetts, United States
Jannik Andersen
Summary
Jannik Andersen is an accomplished Chief Scientific Officer at Tango Therapeutics, specializing in biological products and drug discovery. With a robust background in biochemistry and clinical development, he has significant experience in both early drug discovery and clinical environments. His expertise spans a wide array of fields, including oncology, biomarkers, and biotechnology, making him a key player in advancing cancer therapeutics. Jannik's career path reflects a strong commitment to innovation in life sciences, having held multiple leadership positions in prominent companies. His academic credentials include a Ph.D. in Human Biology from the University of Copenhagen, underscoring his solid foundation in scientific research. Jannik is also an active contributor to the scientific community, with numerous publications focused on cancer biology and drug development. His leadership style is characterized by collaboration with academic and corporate partners, fostering an environment of shared knowledge and progress.
Jannik Andersen
Work Experience
Chief Scientific Officer at
Tango Therapeutics
October 2023 - Present
Senior Vice President Biology at
Tango Therapeutics
January 2022 - October 2023
Vice President, Head of Biology at
Tango Therapeutics
January 2019 - December 2021
Vice President, Head of Research at
Xios Therapeutics
February 2018 - January 2019
Vice President Drug Discovery at
Xtuit Pharmaceuticals
August 2014 - January 2018
Sr. Associate Director Drug Discovery at
The University of Texas M D Anderson Cancer Center
October 2011 - August 2014
Associate Director at
Harvard University
August 2010 - October 2011
Research Fellow at
Merck
August 2009 - August 2010
Sr. Research Biologist at
Merck
May 2006 - July 2009
Sr. Fellow at
Cold Spring Harbor Laboratory Association, Inc.
August 2005 - February 2007
Postdoctoral fellow at
Cold Spring Harbor Laboratory Association, Inc.
August 2001 - August 2005
Consultant at
Novo Nordisk
May 2001 - July 2001
Ph.D. Educational Trainee at
Novo Nordisk
May 1998 - April 2001
Jannik Andersen
Education
University of Copenhagen, Ph.D.
January 1998 - January 2001
University of Copenhagen, Panum Institute, M.Sc.
January 1996 - January 1998
Danmarks Tekniske Universitet, M.Sc., Chemical Engineering
January 1990 - January 1998
University of Calgary, Thesis Project
January 1994 - January 1995
Institut polytechnique de Grenoble, Erasmus Scholar
January 1992 - January 1993
Frequently Asked Questions about Jannik Andersen
What is Jannik Andersen email address?
Jannik Andersen's primary email address is *********@tangotx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Jannik Andersen work for?
Jannik Andersen is a Chief Scientific Officer at Tango Therapeutics, a company specializing in Commercial physical research.
Where Jannik Andersen graduated from?
Jannik Andersen holds a degree in Human Biology from University of Copenhagen.
How can I directly contact Jannik Andersen?
To contact Jannik Andersen directly, you can use the email address *********@tangotx.com. Complete contact information is available upon registration with Muraena.
Who is Jannik Andersen?
Jannik Andersen is an accomplished Chief Scientific Officer at Tango Therapeutics, specializing in biological products and drug discovery. With a robust background in biochemistry and clinical development, he has significant experience in both early drug discovery and clinical environments. His expertise spans a wide array of fields, including oncology, biomarkers, and biotechnology, making him a key player in advancing cancer therapeutics. Jannik's career path reflects a strong commitment to innovation in life sciences, having held multiple leadership positions in prominent companies. His academic credentials include a Ph.D. in Human Biology from the University of Copenhagen, underscoring his solid foundation in scientific research. Jannik is also an active contributor to the scientific community, with numerous publications focused on cancer biology and drug development. His leadership style is characterized by collaboration with academic and corporate partners, fostering an environment of shared knowledge and progress.
Jannik`s contact details
*********@tangotx.com
Colleagues
Senior Vice President Communications
Board Member, Audit Committee Chair
Senior Vice President, Head of Business Development and Alliance Management
Executive Director, Biochemistry
Board Member
Co-Founder
Executive Director, Medicinal Chemistry
Chief Development Operations Officer
Senior Vice President